1999
DOI: 10.1006/exer.1999.0731
|View full text |Cite
|
Sign up to set email alerts
|

Adenovirus-Mediated Gene Transfer of Interleukin-4 to Corneal Endothelial Cells and Organ Cultured Corneas Leads to High IL-4 Expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
29
0

Year Published

2000
2000
2013
2013

Publication Types

Select...
9
1

Relationship

7
3

Authors

Journals

citations
Cited by 35 publications
(31 citation statements)
references
References 21 publications
2
29
0
Order By: Relevance
“…The AdBcl-xL and AdNull adenoviral vectors were generated, propagated and purified as described before (Fallaux et al, 1996;Ritter et al, 1999). The AdshRNA-C9 and AdshRNA-eGFP vectors were generated using the ViraPower adenovirus expression system (Invitrogen).…”
Section: Adenoviral Vector Production and Transductionmentioning
confidence: 99%
“…The AdBcl-xL and AdNull adenoviral vectors were generated, propagated and purified as described before (Fallaux et al, 1996;Ritter et al, 1999). The AdshRNA-C9 and AdshRNA-eGFP vectors were generated using the ViraPower adenovirus expression system (Invitrogen).…”
Section: Adenoviral Vector Production and Transductionmentioning
confidence: 99%
“…The generation of recombinant E1-deleted replicationincompetent adenovirus type 5 vectors carrying the genes encoding β−galactosidase (Adβ-Gal) and rat IL-4 (AdrIL-4), respectively, has been described elsewhere [18,19]. Primary PSC activated by in vitro cultivation for 7 to 10 days after isolation from rat pancreas were used as target cells.…”
Section: Adenovirus Vectors and Cell Transductionmentioning
confidence: 99%
“…As the main target of corneal allograft rejection [11], corneal endothelial cells are more suitable than other corneal cell types for cytokine gene transfer studies. Previously, gene transfer to corneal endothelium using recombinant adenovirus (Ad) has been described [12][13][14][15]. However, the widely used Ad vectors have several undesired side-effects, and immunestimulating properties of the virus may limit the benefits of recombinant Ad for purposes of immune suppression [16].…”
Section: Introductionmentioning
confidence: 99%